Follow the DIASORIN share price and the full insider trade history of the company, a listed equity based in Italy. Shares trade on the IT market, under the authority of Consob. Operating in the Health Care sector, DIASORIN has published 35 insider filings. Market capitalisation: €3.3bn. The latest transaction was disclosed on 10 November 2025 (Other). Among the most active insiders: CHEN MENACHEM EVEN. The full history is openly available.
35
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€43m
33 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate DIASORIN Hold (neutral), based on 14 analysts. Average price target: €70.16.
15Σ signal
Buys n/a€43m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,494 of 29,063 companies
61.9
score / 100
Value
58
Quality
66
FCF yld5.5%
Earn yld4.2%
EV/EBITDA12.3x
ROE9.2%
Gross mgn65%
Net mgn13%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.